期刊文献+

HE4对卵巢恶性肿瘤鉴别及与病理特征的关系研究

Study on the identification of malignant ovarian tumor and relationship between HE4 and pathological characteristics
下载PDF
导出
摘要 目的:探讨人附睾蛋白4(HE4)对卵巢恶性肿瘤鉴别及与病理特征的关系。方法:收治卵巢肿瘤患者210例,分为观察1组、观察2组。选取健康女性100例作为对照组。检测3组的血清HE4水平。结果:观察1组血清HE4水平明显高于观察2组、对照组,差异具有统计学意义(P<0.05)。观察2组血清HE4水平与对照组间相比,差异无统计学意义(P>0.05)。低分化级阳性率高于中高分化级阳性率,早期卵巢癌阳性率低于晚期卵巢癌阳性率,差异具有统计学意义(P<0.05)。结论:HE4是较好的诊断卵巢恶性肿瘤的标志物,其水平与病理特征具有一定的相关性。 Objective:To investigate the identification of malignant ovarian tumor and relationship between HE4 and pathological characteristics.Methods:210 cases of patients with ovarian tumor were divided into the observation group 1 and the observation group 2.100 cases of healthy women were as the control group.The serum HE4 levels in the three groups were detected.Results:The serum HE4 level of the observation group 1 was significantly higher than that of the observation group 2 and the control group,and the differences were statistically significant (P<0.05).There was no significant difference between the observation group 2 and the control group (P>0.05).The positive rate of the low differentiation grade was higher than that of the middle and high differentiation grade,and the positive rate of early ovarian cancer was lower than that of the advanced ovarian cancer,and the difference was statistically significant (P<0.05).Conclusion:HE4 was good marker for diagnosis of malignant ovarian tumor,and its level had a certain correlation with pathological characteristics.
作者 田芳 赵洁 王玥元 Tian Fang;Zhao Jie;Wang Yueyuan(Corresponding author)(The Maternal and Child Health Hospital of Gansu Province 730050)
出处 《中国社区医师》 2016年第31期123-123,125,共2页 Chinese Community Doctors
关键词 卵巢恶性肿瘤 人附睾蛋白4 鉴别 病理特征 Ovarian malignant tumor Serum human epididymis protein 4 Identification Pathological characteristics
  • 相关文献

参考文献4

二级参考文献40

  • 1班慧敏.血清CA125、CA199、和CA724联合检测对卵巢癌的诊断价值[J].中国当代医师,2011,18(17):38.
  • 2Kadija Sasa, Stefanovic Aleksandar,Jerem ic Katarina, etal. The Utility of Human Epididymal Protein 4,Cancer Antigen 125, and Risk for Malignancy Algorithm in Ovarian Cancer and Endom etriosis[J]. International Journal of Gynecological Cancer, 2012, 22(2) :238.
  • 3Fioretti P Gaddueei A, Ferdeghini M et al. The concomitant de termination of dierent serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow up of patients [J]. Gynecol Onco1,1992,44:155.
  • 4Kirchhoff C,Habben I,Ivell R. A major human epididymis specific cDNA encodes a protein with sequence homology to extracellular protein as inhibitors[J].{H}Biology of Reproduction,1991,(02):350-357.
  • 5Hellstrom I,Raycraft J,Hayden L. The HE4 (WFDC2)protein is a biomarker for ovarian carcinoma[J].{H}CANCER RESEARCH,2003,(13):3695-3700.
  • 6Drapkin R,Horsten HH,Lin Y. Human eipididymisprotein 4(HE4) is a secreted glycoprotein that is over-expressed by serous and endometrioid ovarian carcinomas[J].{H}CANCER RESEARCH,2005,(06):2162-2169.
  • 7Wang K,Gan L,Jeffrey E,et ak. Monitoring genes expression profile changes in ovarian carcinomas using cDNA microarray[J].{H}GENE,1999,(1/2):101-108.
  • 8Huhtinen K,Suvitie P,Hiissa J. Serum HE4 concentration differentiatesm maignant ovarian tumours from ovarian endometriotic cysts[J].{H}British Journal of Cancer,2009,(08):1315-1319.
  • 9Moore RG,Mcmeekin DS,Brown AK. A nove multiple marker bioassay utlizing HE4 and CA125 for the pred iction of ovarian cancer in patients with a pevic mass[J].Gyneco Onco,2009,(01):40-46.
  • 10邵 婷,陈秀玮.卵巢癌的病因假说及危险因素和流行病学研究进展[J/CD].中华临床医师杂志(电子版),2013,7(19):8894-8897.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部